A specific nuclear DNA background is required for high frequency lymphoma development in transmitochondrial mice with G13997A mtDNA

PloS One
Osamu HashizumeJun-Ichi Hayashi

Abstract

We previously found that mouse mitochondrial DNA (mtDNA) with a G13997A mutation (G13997A mtDNA) controls not only the transformation of cultured lung carcinoma cells from poorly metastatic into highly metastatic cells, but also the transformation of lymphocytes into lymphomas in living C57BL/6 (B6) mice. Because the nuclear genetic background of the B6 strain makes the strain prone to develop lymphomas, here we examined whether G13997A mtDNA independently induces lymphoma development even in mice with the nuclear genetic background of the A/J strain, which is not prone to develop lymphomas. Our results showed that the B6 nuclear genetic background is required for frequent lymphoma development in mice with G13997A mtDNA. Moreover, G13997A mtDNA in mice did not enhance the malignant transformation of lung adenomas into adenocarcinomas or that of hepatocellular carcinomas from poorly metastatic into highly metastatic carcinomas. Therefore, G13997A mtDNA enhances the frequency of lymphoma development under the abnormalities in the B6 nuclear genome, and does not independently control tumor development and tumor progression.

References

Sep 1, 1995·Molecular Carcinogenesis·L A DonehowerA Bradley
Jun 30, 1995·Science·N PapadopoulosK W Kinzler
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·M OshimaM Taketo
Jul 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M HarveyL A Donehower
May 22, 1998·Trends in Genetics : TIG·A Balmain, H Nagase
Nov 7, 1998·Nature Genetics·K PolyakB Vogelstein
Mar 5, 1999·Science·D C Wallace
Nov 4, 2000·Nature Genetics·S Niemann, U Müller
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Giacomo ManentiTommaso A Dragani
Jan 18, 2005·Biochemical and Biophysical Research Communications·Miho AkimotoJun-Ichi Hayashi
Apr 30, 2005·Nature Reviews. Genetics·Robert W Taylor, Doug M Turnbull
Dec 6, 2005·Nature Reviews. Cancer·Eyal Gottlieb, Ian P M Tomlinson
Jul 5, 2006·Cancer Research·Dan FreemanHong Wu
Apr 5, 2008·Science·Kaori IshikawaJun-Ichi Hayashi
Apr 25, 2008·Nature Reviews. Cancer·Debra M KrupkeJanan T Eppig
Sep 23, 2008·FEBS Letters·Kaori IshikawaJun-Ichi Hayashi
Mar 5, 2010·Nature·Yiping HeNickolas Papadopoulos
Apr 22, 2011·Nature Reviews. Cancer·Willem H KoppenolChi V Dang
Jun 13, 2012·Proceedings of the National Academy of Sciences of the United States of America·Osamu HashizumeJun-Ichi Hayashi
Feb 11, 2014·Proceedings of the National Academy of Sciences of the United States of America·Akinori ShimizuJun-Ichi Hayashi

❮ Previous
Next ❯

Citations

Apr 15, 2016·Current Opinion in Genetics & Development·Jun-Ichi HayashiAkinori Shimizu
May 8, 2018·Genes·Giulia LeoneLuisa Iommarini
Oct 16, 2015·Oncotarget·Jose M Garcia-Heredia, Amancio Carnero
Nov 4, 2017·Cancer Research·Karen M Bussard, Linda D Siracusa

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

FlowJO

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.